Promoting consistent use of prescription drug monitoring programs (PDMP) in outpatient pharmacies: Removing administrative barriers and increasing awareness of Rx drug abuse

Research in Social and Administrative Pharmacy

Volumn 12, Issue 3, 2016, Pages 509-514

  Norwood, Connor W ^a,b,c   Wright, Eric R ^a,b,d  

^a INDIANA UNIVERSITY   (United States)

^b INDIANA UNIVERSITY   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Barriers; Outpatient pharmacists; Outpatient pharmacy; PDMP; Pharmacists; Pharmacy practice; Prescription drug abuse; Prescription drug monitoring program

Indexed keywords

PRESCRIPTION DRUG;

ADULT; FEMALE; HEALTH PERSONNEL ATTITUDE; HUMAN; INDIANA; MALE; MIDDLE AGED; ORGANIZATION AND MANAGEMENT; OUTPATIENT DEPARTMENT; PHARMACY; PRESCRIPTION DRUG MISUSE;

ADULT; AMBULATORY CARE FACILITIES; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HUMANS; INDIANA; MALE; MIDDLE AGED; PHARMACEUTICAL SERVICES; PHARMACIES; PRESCRIPTION DRUG MISUSE; PRESCRIPTION DRUGS;

EID: 84940116992     PISSN: 15517411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.sapharm.2015.07.008     Document Type: Article

References (13)

1. Quality improvement guidelines for the treatment of acute pain and cancer pain. American Pain Society Quality of Care Committee. J Am Med Assoc 1995, 274:1874-1880.
2. CDC grand rounds: prescription drug overdoses - a U.S. epidemic. MMWR Morb Mortal Wkly Rep 2012, 61:10-13. Centers for Disease Control Prevention.
3. Rudd R.A., Paulozzi L.J., Bauer M.J., et al. Increases in heroin overdose deaths-28 states, 2010 to 2012. MMWR Morb Mortal Wkly Rep 2014, 63:849-854.
4. The Role of a Prescription Drug Monitoring Program in Reducing Prescription Drug Diversion, Misuse, and Abuse 2014, NAMSDL, National Alliance for Model State Drug Laws.
5. Blumenschein K., Fink J., Freeman P.R., et al. Review of Prescription Drug Monitoring Programs in the United States 2010, 1-28. Institute for Pharmaceutical Outcomes and Policy.
6. Briefing on PDMP Effectiveness 2014, PDMP Center of Excellence, Brandeis University: Bureau of Justice Assistance.
7. Norwood C.W., Wright E.R. Integration of prescription drug monitoring programs (PDMP) in pharmacy Practice: Improving clinical decision-making and supporting a Pharmacist's professional judgment. Res Social Adm Pharm 2016, 12:257-266.
8. Maxwell L., Odukoya O.K., Stone J.A., Chui M.A. Using a conflict conceptual framework to describe challenges to coordinated patient care from the physicians' and pharmacists' perspective. Res Social Adm Pharm 2014, 10:824-836.
9. Fleming M.L., Barner J.C., Brown C.M., Shepherd M.D., Strassels S.P., Novak S.M. Using the theory of planned behavior to examine pharmacists' intention to utilize a prescription drug monitoring program database. Res Social Adm Pharm 2014, 10:285-296.
10. Kooreman H., Carnes N., Wright E. Key Findings and Recommendations from the 2013 IPLA INSPECT Knowledge and Use Survey 2014, Center for Health Policy: Indiana University.
11. Maxey H.L. Indiana Pharmacist 2012 Licensure Survey Data. Indiana University Health Workforce Studies 2015.
12. Menard S. Applied Logistic Regression Analysis 2002, Sage, Thousand Oaks, CA.
13. Rutkow L., Turner L., Lucas E., Hwang C., Alexander G.C. Most primary care physicians are aware of prescription drug monitoring programs, but many find the data difficult to access. Health Aff (Millwood) 2015, 34:484-492.